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Summary Although animals bearing the MAC16 colon adenocarcinoma showed progressive weight loss, the
average food consumption (15.1 ± 0.6 Kcal day-') did not differ from non tumour-bearing controls
(15.3 ± 0.3 Kcal day-'), while animals bearing a related colon adenocarcinoma, MAC13, which had no effect
on body weight had a significantly (P<0.01) elevated food intake (16.4 ± 0.3 Kcal day-') above controls.
Weight loss in animals bearing the MAC16 tumour was associated with a significant reduction in the
percentage contribution of the kidneys, colon and epididymal fat pads to the total body weight. Although loss
of body fat occurred only in the MAC16 model, both tumours were capable of synthesising lipids from
glucose both in vitro and in vivo at the same rate. In addition both tumours increased the rate of lipogenesis
from glucose in kidney, liver and epididymal fat pads of the host. Lipogenesis from glucose would be expected
to result in a loss of utilisable carbohydrate energy and thus would be expected to increase the overall energy
requirements in the tumour-bearing state leading to catabolism of host body tissues if the energy intake is not
increased.
The principal endogenous energy and nitrogen sources during
evolution of weight loss in cancer are primarily adipose tissue
triglycerides and skeletal muscle proteins (Heymsfield &
McManus, 1985) and loss of body fat accounts for a major
portion of weight loss in cancer patients (Watson & Sam-
mon, 1980). Studies on weight losing cancer patients have
shown that the whole body lipolytic rate is not different from
healthy controls, suggesting that the loss of body fat in
patients with cancer cachexia may be due to a reduced rate
of lipogenesis rather than the ..ugmented lipolysis (Jeevanan-
dam et al., 1986). Studies on tumour-bearing animals have
reported either no change (Thompson et al., 1981; Lanza-
Jacoby et al., 1982) or a decrease (Kannon et al., 1980;
Lanza-Jacoby et al., 1984) in lipogenesis. However, we have
recently reported an increase in the specific activity of fatty
acid synthase in the host livers of animals bearing either the
cachexia-inducing colon adenocarcinoma (MAC16) or the
related colon adenocarcinoma (MAC13), which does not
induce cachexia in recipient animals (Tisdale & Leung, 1988).
This suggests that host lipogenesis may be increased in the
tumour-bearing state irrespective of the effect of the tumour
on host adipose tissue.
Tumours require fatty acids for oxidative metabolism, for
membrane lipids and as a source ofmetabolic regulators such
as eicosanoids and diacylglycerol. Although some tumours
have been reported to synthesise fatty acids de novo it is
generally accepted that most of the host lipid requirements
are met from the host (Spector, 1975). In this context, we
have compared the synthetic ability of the two colon adeno-
carcinomas, MAC16 and MAC13 both in vitro and in vivo to
ascertain whether differences in host lipid depletion arise
from differences in the biosynthetic capacity of the two
tumours. In addition the lipogenic response of host tissues to
the presence of the two tumours has been evaluated.
Material and methods
Pure strain NMRI mice were bred in our own colony and
were fed a rat and mouse breeding diet (Pilsbury, Birming-
ham, UK) and water ad libitum. Fragments of either the
MAC16 or MAC13 tumour were implanted into the flank of
male NMRI mice by means of a trocar as described (Beck &
Tisdale, 1987; Bibby et al., 1987). Animals bearing the
MAC16 tumour developed weight loss 10 to 12 days follow-
ing tumour transplantation (average tumour weight 200mg)
and when weight loss was prolonged the animals were
regarded as cachectic (average weight loss 2 to 4 g). Animals
bearing the MAC13 tumour were used 10 to 12 days follow-
ing tumour transplantation, when the tumour became pal-
pable (average weight 200mg), and were matched in body
weight to those bearing the MAC16 tumour.
Both the MAC13 and MAC16 cell lines were derived from
the solid tumours and were maintained in vitro in RPMI
1640 tissue culture medium containing 10% foetal calf serum
under an atmosphere of 5% CO2 in air.
Determination oflipogenesisfrom glucose
D-[U-'4C] Glucose (sp.act. 270 m Cimmol') (Amersham In-
ternational, Bucks, UK) was administered to male NMRI
mice by i.p. injection (250 yCi Kg-') in 0.2ml of normal
saline. Three hours after injection, animals were anaesthe-
tised and blood was removed by cardiac puncture. The fol-
lowing organs were dissected out and weighed; epididymal
fat pads, spleen, liver, kidneys, colon, brain and tumour.
Lipids were extracted from the blood and organs by the
method of Stansbie et al. (1976). Organs were heated in 3 ml
of 30% (w/v) KOH for 15 min at 70°C, followed by the
addition of 3 ml of 95% ethanol, and heating was continued
for a further 2 h. The saponified material was then cooled,
acidified with 3 ml of 9 M sulphuric acid, and the lipids were
then extracted into petroleum ether (B.P. 40-60°). The ether
fractions were allowed to evaporate to dryness and the
radioactivity in the residue was determined in Optiphase
scintillation fluid.
For in vitro determinations MAC16 (1.5 x 106 cells) or
MAC13 (0.75 x 106 cells) were suspended in RPMI 1640
medium containing 0.2 yCi ml-' D-[U-'4C]glucose. At
specified time intervals over a 48 h period, lipids were ex-
tracted according to the method described above.
Determination oflipogenesisfrom 3H2O
Animals were injected i.p. with 3H20 (sp.act. Sm Ci ml-') at
a concentration of 10 mCi Kg-'. Three hours after injection,
animals were anaesthetised, blood was removed by cardiac
puncture and the lipid levels of the organs was determined as
above.
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Acetyl-CoA carboxylase
This was determined by assaying the activity after maximal
activation with citrate (Inoue & Lowenstein, 1969). Livers
from three mice were combined and homogenised in two
volumes of 50 mM Tris, pH 7.5, 20 mM sodium citrate,
0.5 mM EDTA and 5 mM 2-mercaptoethanol. The homogen-
ate was sequentially centrifuged and re-extracted as described
(Inoue & Lowenstein, 1969). The supernatant (0.5 ml) from
a 105,000g centrifugation was applied to a column of
Sephadex G-25 (column volume 10 ml) which had been
equilibrated with 20 mM Tris, pH 7.5 containing 1 mM
dithiothreitol and eluted with the same buffer. The fractions
with the highest protein content were pooled and used as the
crude enzyme, which was activated in 20 mM sodium citrate,
20 mM MgCl2, 1 mM dithiothreitol, 50 mM Tris, pH 7.5 plus
0.5 mg ml-' bovine serum albumin for 30 min at 37°C.
Acetyl-CoA carboxylase activity was then immediately
assayed by dilution into 10 mM Tris, pH 7.5, 1 mM dithio-
threitol, 0.2 mM acetyl-CoA, 20 mM NaH'4C03
(0.25 IACi jsmole '), 5 mM ATP, 20 mM citrate, 20 mM MgCl2
and bovine serum albumin (0.5 mg ml-1). The mixture was
incubated at 37°C for 5 min and stopped by acidification
with 0.1 ml 4N HCI, and the samples were dried. The residue
was dissolved in water and the radioactivity was determined
in Optiphase scintillation fluid. The experiment was repeated
five times.
Citrate
This was determined by the UV spectrophotometric assay as
described by Dagley (1974).
Statistical analysis
All results were expressed as mean ± s.e.m. for at least three
separate determinations. Differences were evaluated statis-
tically by Student's t-test.
Results
The effect of the MAC16 and MAC13 tumour on the organ
weights of male NMRI mice is shown in Figure 1. Animals
bearing the MAC16 tumour showed a significant decrease in
the wet weight of the brain, colon, kidneys and epididymal
fat pads when compared with non tumour-bearing animals or
animals bearing the MAC13 tumour. To allow for the
decrease in total body weight of animals bearing the MAC16
tumour, organ weights have also been expressed as a percent-
age of the total body weights (Figure 2). In cachectic
animals, the kidneys, colon and epididymal fat pads all
showed a significant reduction in the percentage contribution
to the total body weight when compared with non tumour-
bearing controls. The apparently increased contribution of
the lungs in tumour-bearing animals may have been due to
the inability to remove blood after extraction. Although
animals bearing the MAC16 tumour lost weight, the daily
food intake per mouse (15.1 ± 0.6 Kcal) did not differ from
that of non tumour-bearing controls (15.3 ± 0.3 Kcal), while
in animals bearing the MAC13 tumour, the daily food intake
(16.4 ± 0.3) was significantly (P<0.01) increased.
Since the MAC16 tumour produced a large decrease in
lipid stores, unlike the MAC13 tumour, the possibility arises
that the MAC16 tumour may be utilising large amounts of
lipid for growth, which it is unable to synthesise. However, in
vitro measurements on the rate of lipogenesis from glucose
show no difference between the two cell lines (1.61 ± 0.17
nmolh-' 106cells-' for MAC16 and 1.46±0.10nmolh-'
106cells-' for MAC13).
The effect of the tumour-bearing state on the rate of
lipogenesis in various organs in vivo was studied using both
the MAC16 and MAC13 tumour models and [U-_4C]glucose
and 3H20 as substrates. In agreement with the in vitro assay
there was no difference between the rates of lipogenesis ofthe
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Figure 1 Organ weights in non tumour-bearing animals (stippled
bars) and in animals bearing the MAC13 (hatched bars) and
MAC16 (solid bars) tumours. Values for the brain (A), lungs (B),
liver (C), kidneys (D), spleen (E), colon (F), epididymal fat pads
(G) and testes (H) are shown. Differences b, P<0.01; c,
P<0.005; d, P<0.001 between tumour-bearing and control
animals were determined by Students t-test.
5-
0
n 3-
-W
o 0 4
' 2
0
0.
0 e
eW
b
bb
am
A B C D' E F G H
Organ
Figure 2 Organ weights in non tumour-bearing animals (stippled
bars) and in animals bearing the MAC13 (hatched bars) and
MAC16 (solid bars) tumours expressed as a percentage of the
total body weight. The symbols are the same as in Figure 1. a,
P<0.05; b, P<0.01 and c, P<0.005. Differences between
tumour-bearing and control animals were determined by Students
t-test.
MAC13 and MAC16 tumours in vivo (Figure 3) using either
assay method.
However, the tumour-bearing state produced profound
alterations in the rate of lipogenesis in specific organs. In
particular, the rates of lipogenesis were significantly elevated
in the liver and epididymal fat pads in the tumour-bearing
state using [U-'4C]glucose (Figure 3) and in the kidney and
epididymal fat pads using 3H20 (Figure 4) and there was no
significant difference in the extent of induction of lipogenesis
in these organs between the cachexia-inducing MAC16
tumour and MAC13 tumour (Figures 3 and 4). However,
using [U-_4C]glucose, lipogenesis was also significantly in-
creased in the kidney of animals bearing the MAC16 tumour
(Figure 3), and using 3H20 lipogenesis was significantly in-
creased in the liver of animals bearing the MAC16 tumour
(Figure 4), while there was no significant elevation in animals
bearing the MAC13 tumour. Thus there appears to be a
stimulation of the conversion of glucose to lipid in the
tumour-bearing host and for the fat pads this is irrespective
of the development of cachexia.
The level of acetyl-CoA carboxylase in the livers of con-
trol, non tumour-bearing animals and in animals bearing the
MAC13 and MAC16 tumours after maximal stimulation byLIPOGENESIS IN TUMOUR-BEARING ANIMALS 721
20-
0 0
x
1-
w-
0 10 0
U
- -a
C
f
c
8
u,I -
e
b
a
A C D E
Organ
Figure 3 Lipogenesis from glucose in v
tumour-bearing animals (stippled bars) a
the MAC13 (hatched bars) and MAC16
D-[U-'4C]glucose was administered and thi
in brain (A), liver (C), kidneys (D), s
epididymal fat pads (G), tests (H), and
mined as described in methods. Differ
P<0.01; c, P<0.005 and d, P<0.001 b
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Figure 4 Lipogenesis from 3H20 in v;
tumour-bearing animals (stippled bars) a
the MAC13 (hatched bars) and MAC16
3H20 was administered and the incorporat
(A), liver (C), kidneys (D), spleen (E), co
pads (G) and tumour (I) was determined a
Differences a, P<0.05; b, P<0.01;
tumour-bearing and control animals were
t-test.
citrate is shown in Table I. In neither
level of acetyl-CoA carboxylase in the
controls. In addition, the concentration
not significantly different in animals b
MAC13 tumours from non tumour-bx
I). In contrast, we have previously sho
1988) that the level of fatty acid synt
increased in the host livers of anim
MAC13 and MAC16 tumours. This
crease in host lipogenesis arises from a
fatty acid synthase.
Discussion
Quantitative estimates of the utilisation
in cancer patients suggest that there m
Table I Effect of tumour type on host liver acetyl-CoA carboxylase
and citrate levelsa
Acetyl-CoA carboxylase
p.mole malonyl-CoA min-'
Tumour type mgprotein-' Citrate pmolg-'
None 0.014 ± 0.001 0.210 ± 0.010
MAC13 0.018 ± 0.002 0.216 ± 0.010
MAC16 0.016 ± 0.002 0.234 ± 0.012
aResults are given as mean ± s.e.m. for 7 to 15 animals per value.
- ~~~~pattern of fuel utilisation with lipid sources predominating
(Young, 1977). This produces an added burden on the host
c 1 as regards substrate availability, and could account for the
a _ marked depletion of body fat seen in cancer cachexia. In
some studies both the daily energy expenditure and the rest-
F G ing metabolic rate have been shown to be significantly
greater in cancer patients than in controls (Warnold et al.,
various organs of non 1978), which may explain the increased rate of removal of
Lnd in animals bearing infused lipids from the blood of cancer patients (Waterhouse
(solid bars) tumours. & Nye, 1961), since fat is an excellent source of energy. Our
e conversion into lipids own studies with the MAC16 tumour would also suggest an
spleen (E), colon (F), increase in metabolic rate, since there is an increase in oxygen
rences a, P<0.05; b consumption and an increased activity of brown adipose
etween tumour-bearing tissue during the period of weight loss (unpublished results). t0.0e and g, P<O.005 Unlike previous reports which have documented either no
bearing animals were change (Thompson et al., 1981; Lanza-Jacoby et al., 1982) or
a decrease (Lanza-Jacoby et al., 1984) in the liver lipogenic
capacity in the tumour-bearing state, we have found an
increase in lipogenesis in host liver, kidney and epididymal
adipose tissue in animals bearing either the cachexia-inducing
MAC16 tumour or the MAC13 tumour using either D-
[U-'4C]glucose or 3H20 as substrate. While the preferred
method for measurement of lipogenesis in vivo uses 3H20 as
substrate, which gives the rate of lipogenesis from C2 units,
whatever the original source of the precursor, the results with
D-[U-'4C]glucose were substantially the same.
Acetyl-CoA carboxylase catalyses the first committed and
rate-limiting step in fatty acid biosynthesis and is activated
c by citrate and inhibited by long chain fatty acyl-CoA (Guynn
8a et al., 1972; Goodridge, 1972). We have previously shown a
reduction in the liver content of the allosteric inhibitor fatty
acyl-CoA in animals bearing both the MAC16 and MAC13
I I _ -tumours (Tisdale & Leung, 1988). The level of citrate has
been reported to be increased in the liver of tumour-bearing
mice (McAllister et al., 1982). However, we have been unable
F G to detect differences in the levels ofcitrate in animals bearing
either the MAC13 or MAC16 tumour from that found in
control animals. In addition there is no difference in the
Lnd in animals bearing activity of acetyl-CoA carboxylase in the livers of tumour-
(solid bars) tumours. bearing mice and control mice after maximal stimulation
tion into lipids in brain with citrate. This suggests that both the increased activity of
lon (F), epididymal fat fatty acid synthase (Tisdale & Leung, 1988) and changes in
Ls described in methods. the levels of regulatory metabolites may be important in
c, P<0.005 between maintaining a high rate of lipogenesis. These results contrast
determined by Students with those obtained after tumour necrosis factor/cachectin
(TNF) administration to rats where acetyl-CoA carboxylase
was increased by 58% 16 h after treatment, accompanied by
tumour type was the an initial elevation of hepatic citrate levels (Grunfeld et al.,
liver increased above 1988).
of citrate in liver was As with changes in fatty acid synthase previously reported
earing the MAC16 or (Tisdale & Leung, 1988) the increased lipogenesis appears not
earing controls (Table to be specific to the cachectic state, but is more related to the
own (Tisdale & Leung, presence of a tumour in an animal. Furthermore, there is no
thase was significantly difference in the rates oflipogenesis between the MAC16 and
als bearing both the MAC13 tumours either in vitro or in vivo, and although both
suggests that the in- tumours are capable of de novo synthesis, both induce an
Ln increased activity of increased rate of lipogenesis in host organs. This suggests
that the lipid requirements of the tumour may exceed its
biosynthetic capacity, or that the tumour-bearing state raises
the requirement of host tissues for lipid, possibly due to
glucose consumption by the tumour (Nolop et al., 1987).
It is difficult to understand why the host lipogenic rate
X ofmajor fuel sources should be higher in animals bearing the MAC colon adeno-
ay be a change in the carcinomas when previous reports with other animal tumours
ri
a
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reported either no change or a decrease in the rate of
lipogenesis. The MAC16 tumour produces extensive loss of
host adipose tissue, which might be expected to be accom-
panied by an increased rate of lipogenesis, but the MAC13
tumour has no effect on host lipid stores.
Another important consequence of the increase in lipo-
genesis is that if glucose or other carbohydrate sources are
first converted into fat before being used to meet the energy
requirements of the host, then there is a reduction in the
amount of utilisable energy obtained from the intake of a
given amount of carbohydrate. Estimates of the loss of
utilisable energy may be between 7 (Krebs, 1972) and
20-30% (Hervey & Tobin, 1983) of the calorific value of the
glucose channelled into lipogenic pathways. Whatever the
precise value, there appears to be a significant energy cost
associated with this process, which may contribute partly to
the loss in body tissues in animals bearing the MAC16
tumour which do not increase their energy intake, and could
explain why animals bearing the MAC13 tumour have a
higher daily energy intake. Thus in the absence of adequate
food intake the animals cannot make up for this wasting of
energy and hence they lose weight.
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